Link Technologies Ltd has announced that the company’s Technical Manager, Dr Catherine McKeen, has been invited as a panellist at this year’s TIDES conference in Las Vegas (20-23 May).
Dr McKeen will share her expertise during a discussion session entitled ‘The Oligo Supply Chain for Diagnostics - Getting your Research to the Market’, taking place on Wednesday, May 23rd at 11:30 am.
The morning’s discussion session will form part of the IBC’s 8th International ‘Applications of Nucleic Acids Technologies for Molecular Diagnostics’ program, being held concurrently with the TIDES Oligonucleotide and Peptide Research, Technology and Product Development Conference.
Working at the cutting edge of nucleotide chemistry, Link Technologies’ research and development team includes highly qualified chemists and application specialists, whose work involves expanding the range of research and medical applications offered by oligonucleotides.
The company’s extensive product catalogue includes reagents for DNA, RNA, PNA & UNA synthesis and modification, while Link also offers fully bespoke custom synthesis and contract manufacturing services.
Many of Link’s products are specifically aimed at the diagnostics market. These include biotin and ferrocene products, as well as a number of fluorophores, quenchers and linkers.